Ligand Pharmaceuticals Inc (NASDAQ:LGND)

155.53
Delayed Data
As of 4:00pm ET
 -0.81 / -0.52%
Today’s Change
95.08
Today|||52-Week Range
170.30
+13.58%
Year-to-Date

Today’s Trading

Previous close156.34
Today’s open154.50
Day’s range152.72 - 158.20
Volume207,878
Average volume (3 months)242,327
Market cap$3.3B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+43.44%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+51.53%
P/E ratio222.2
Price/Sales19.42
Price/Book9.58

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-15.06-11.38%
PBHPrestige Brands Hold...+0.64+1.86%
MDCOMedicines Co-1.79-5.66%
ICPTIntercept Pharmaceut...+0.42+0.71%
Data as of 4:15pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)$1.14
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts